Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable Non-small Cell Lung Cancer (NSCLC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06690541
What this trial is testing

Real-world Study of Local Therapy Changes During 1L Lorlatinib in Unresectable ALK+ NSCLC

Who this might be right for
Lung Cancer, Non-Small Cell
Peking University Cancer Hospital & Institute 100
Large-scale testing (Phase 3)WithdrawnNCT00041171
What this trial is testing

Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery

Who this might be right for
Adult Solid TumorBreast CancerHead and Neck Cancer+3 more
Alliance for Clinical Trials in Oncology
Early research (Phase 1)Study completedNCT00776698
What this trial is testing

Avastin (Bevacizumab) in Combination With Thoracic Radiation and Chemotherapy in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer.

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 1
Not applicableStudy completedNCT01333007
What this trial is testing

An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 423
Large-scale testing (Phase 3)Ended earlyNCT02049151
What this trial is testing

Tecemotide Following Concurrent Chemo-radiotherapy for Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
EMD Serono 35
Early research (Phase 1)Study completedNCT05303493
What this trial is testing

Camu-Camu Prebiotic and Immune Checkpoint Inhibition in Patients With Non-small Cell Lung Cancer and Melanoma

Who this might be right for
NSCLC Stage IVMelanoma Stage IVUnresectable Melanoma+1 more
Centre hospitalier de l'Université de Montréal (CHUM) 45
Large-scale testing (Phase 3)Study completedNCT02125461
What this trial is testing

A Global Study to Assess the Effects of MEDI4736 Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 713
Not applicableActive Not RecruitingNCT04056247
What this trial is testing

Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments

Who this might be right for
Stage IV Non-small Cell Lung CancerStage IV Malignant MelanomaStage IV Small Cell Lung Cancer+2 more
OncoHost Ltd. 10,000
Post-approval studies (Phase 4)Looking for participantsNCT06908070
What this trial is testing

Chemoradiotherapy With Surgery Followed by Consolidation Durvalumab

Who this might be right for
Non-small Cell Lung Cancer Stage III
Idris Bahce 38
Early research (Phase 1)WithdrawnNCT01731587
What this trial is testing

Anti-cancer MUC1-specific Immunotherapy for Unresectable Stage III Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer (NSCLC) Stage III
Merck KGaA, Darmstadt, Germany
Early research (Phase 1)Study completedNCT00032032
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 69
Not applicableActive Not RecruitingNCT05049044
What this trial is testing

Observational Prospective Study of Quality of Life in Unresectable TNM Stage III NSCLC (OBSTINATE)

Who this might be right for
Non-Small Cell Lung Cancer
Groupe Francais De Pneumo-Cancerologie 413
Early research (Phase 1)Study completedNCT00633724
What this trial is testing

Multiple-Vaccine Therapy in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Fukushima Medical University 9
Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Ended earlyNCT02147990
What this trial is testing

Multicenter Study of Rociletinib Administered to Patients With Previously Treated Mutant EGFR Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Clovis Oncology, Inc. 318
Testing effectiveness (Phase 2)Study completedNCT01159288
What this trial is testing

Trial of a Vaccination With Tumor Antigen-loaded Dendritic Cell-derived Exosomes

Who this might be right for
Non Small Cell Lung Cancer
Gustave Roussy, Cancer Campus, Grand Paris 41
Not applicableNot Yet RecruitingNCT07035860
What this trial is testing

Efficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable Locally Advanced Non-small Cell Lung Cancer

Who this might be right for
Carbon Ion Radiotheray
Ji Yongling 34
Large-scale testing (Phase 3)UnknownNCT00077220
What this trial is testing

Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Testing effectiveness (Phase 2)Study completedNCT01652820
What this trial is testing

Chemotherapy/Radiotherapy Versus Concomitant Chemotherapy Followed by Radiotherapy in Stage IIIB Non-small Cell Lung Cancer

Who this might be right for
Non Small-cell Lung Cancer
Spanish Lung Cancer Group 140
Early research (Phase 1)Study completedNCT03236935
What this trial is testing

Phase Ib of L-NMMA and Pembrolizumab

Who this might be right for
Non-Small Cell Lung CancerMalignant MelanomaHead and Neck Squamous Cell Carcinoma+3 more
The Methodist Hospital Research Institute 12
Next Page